ArpitaDesaiMD

PubMed

• 19 citations
  TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor.
  Ivan de Kouchkovsky, Li Zhang, Errol J. Philip, Francis Wright, Daniel M Kim, Divya Natesan, Daniel Kwon, Hansen Ho, Son Ho, Emily Chan, Sima P. Porten, Anthony C. Won...> ;Journal for Immunotherapy of Cancer. 2021 May 1
• 11 citations
  Differential treatment outcomes in BRCA1/2-, CDK12-, and ATM-mutated metastatic castration-resistant prostate cancer.
  Daniel Kwon, Jonathan Chou, Steven Yip, Melissa A. Reimers, Li Zhang, Francis Wright, Hala T. Borno, Arpita Desai, Rahul Aggarwal, Alexander W. Wyatt, Eric J. Small, A...> ;Cancer. 2021 Jun 15
• Evaluating determinants of receipt of molecular imaging in biochemical recurrent prostate cancer
  Hala T. Borno, Tracy Kuo Lin, Anobel Y. Odisho, Arpita Desai, Vadim S. Koshkin, Kalin Werner, Nichole Legaspi, Matthew D. Bucknor, Alexander Bell, Sylvia Zhang, Thomas...> ;Cancer Medicine. 2021 Jan 1
• 13 citations
  Outcomes With First-Line PD-1/PD-L1 Inhibitor Monotherapy for Metastatic Renal Cell Carcinoma (mRCC): A Multi-Institutional Cohort.
  Pedro C. Barata, Whitley Hatton, Arpita Desai, Vadim S. Koshkin, Ellen Jaeger, Charlotte Manogue, Patrick Cotogno, Malcolm Light, Brian E. Lewis, Jodi Lyn Layton, Oliv...> ;Frontiers in Oncology. 2020 Oct 22
• 163 citations
  Kidney cancer, version 1.2021: Featured updates to the nccn guidelines
  Robert J. Motzer, Eric Jonasch, Shawna L. Boyle, Maria I. Carlo, Brandon Manley, Neeraj Agarwal, Ajjai Alva, Katy Beckermann, Toni K. Choueiri, Brian A. Costello, Itha...> ;Journal of the National Comprehensive Cancer Network. 2020 Sep 1
• 14 citations
  Treatment of advanced renal cell carcinoma patients with cabozantinib, an oral multityrosine kinase inhibitor of MET, AXL and VEGF receptors.
  Arpita Desai, Eric J. Small> ;Future Oncology. 2019 Jun 11
• 84 citations
  Inherited predisposition to malignant mesothelioma and overall survival following platinum chemotherapy
  Raffit Hassan, Betsy Morrow, Anish Thomas, Tom Walsh, Ming K. Lee, Suleyman Gulsuner, Meghana Gadiraju, Vasiliki Panou, Shaojian Gao, Idrees Mian, Javed Khan, Mark Raf...> ;Proceedings of the National Academy of Sciences of the United States of America. 2019 Apr 30
• 128 citations
  Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma
  Vasiliki Panou, Meghana Gadiraju, Arthur Wolin, Caroline M. Weipert, Emily Skarda, Aliya N. Husain, Jyoti D. Patel, Buerkley Rose, Shannon R Zhang, Madison Weatherly, ...> ;Journal of Clinical Oncology. 2018 Aug 16
• 69 citations
  FGFR signaling as a target for Lung cancer therapy
  Arpita Desai, Alex A. Adjei> ;Journal of Thoracic Oncology. 2016 Jan 1
• 5 citations
  Pneumonectomy-Sparing NSAID Therapy for Pulmonary Inflammatory Myofibroblastic Tumor
  Sofia Ghani, Arpita Desai, Saraswati Pokharel, Todd L. Demmy, Grace K. Dy> ;Journal of Thoracic Oncology. 2015 Sep 1
• 1 citations
  Progressive chronic lymphocytic leukemia after allogeneic hematopoietic cell transplantation.
  Potjana Jitawatanarat, Arpita Desai, Pradeep Sharda, Hong Liu, Maureen Ross, Francisco J Hernandez-Llizaliturri, Philip L. McCarthy, George Chen> ;Journal of the National Comprehensive Cancer Network. 2012 Oct 1
• Join now to see all

Lectures

• Phase II trial of pembrolizumab (P) in patients (pts) with previously-treated mesothelioma (MM). 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/3/2018